ENTPD1 and COVID-19: Compared to both healthy donor cohorts, we observed that more SARS-CoV-2-reactive T cells from COVID-19 patients expressed the activation markers CD38, CD39, CD69 and HLA-DR, and showed a late-differentiated effector memory profile of reduced CD27 (Fig. 4A).